glp-1-based therapy GLP-1 receptor agonists are transforming diabetes care by improving blood sugar control, supporting weight loss, and reducing cardiovascular risk when used appropriately. Evidence-based selection, correct dosing, and patient counseling are How GLP-1 Medications Boost Weight

Patients taking GLP-1 RAs were reported to have a 4tenfold increase in RGC compared to controls that were not on any medications that delay gastric emptying (Kobori et al

This means food stays in the stomach longer, which can lead to longer-lasting fullness and fewer intense hunger spikes

However, the effect is generally modest compared with prescription GLP-1 receptor agonists

Pergolizzi, The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Agonists for Polycystic Ovary Syndrome

A study in ( JAMA Ophthalmology (June 5, 2025) reported that people with type-2 diabetes using GLP-1 receptor agonists appear to have a higher risk of neovascular age-related macular degeneration (AMD) the wet form of the disease

Its an area of active research, with studies being done to support these initial benefits and reveal new ones.